Navigation Links
EffRx Announces Issuance of US Patent Providing Further Protection to EX101, Effervescent Alendronate Weekly Dosing Form
Date:7/11/2011

LAUSANNE, Switzerland, July 11, 2011 /PRNewswire/ --


EffRx Pharmaceuticals SA, an Epalinges/Lausanne, Switzerland based drug delivery company, announces that US patent 7,964,212 was issued on June 21, 2011, enhancing the protection of EX101.

This patent grants significant additional Intellectual Property concerning the EffRx Lead Program, EX101 (70 mg effervescent alendronate for the treatment of osteoporosis).

The extended range of intellectual property in this patent protects effervescent formulations of all the orally administered bisphosphonate osteoporosis medications including risedronate and ibandronate, when delivered in the highly buffered EX101 formulation. The formulation is unique in that it delivers the bisphosphonate to the stomach in a proprietary buffered solution which prevents exposure of the stomach or esophagus to strongly acidified bisphosphonate forms, which are believed to be damaging forms of this drug class.  

Additional claims related to the buffering composition and method of manufacturing were also granted.

An NDA for EX101 has been filed by the FDA. Nycomed has licensed EX101 for territories outside the United States, Canada and Japan, and the product is in registration in many countries.

"There are more and more reports around the world that generic alendronate products have even more GI-side effect problems and thereby less patient compliance than branded bisphosphonate products. We strongly believe that EX101 fills an unmet need of patients, doctors, and payers around the world since poor compliance leads to escalating health costs due to osteoporosis related fractures" stated Christer Rosén, Chairman and CEO.

About EffRx

EffRx is a privately held drug delivery technology company specializing in the utilization of proprietary effervescent technology to develop formulations that improve efficiency, compliance and convenience of existing prescription drugs.

<
'/>"/>
SOURCE EffRx Pharmaceuticals S.A.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Generex Announces Publication of Studies with the Mayo Clinic Confirming and Extending the Antigen Express Ii-Key Platform Technology
2. RegenoCELL Announces That Patients Can Be Treated With Its Autologous Stem Cell Therapy in Greece
3. Saladax Biomedical, Inc. Announces Appointment of Gregory C. Critchfield, M.D., M.S. as Chairman of the Companys Board of Directors
4. Rosetta Genomics Announces One-For-Four Reverse Stock Split
5. Generex Announces U.S. Congressman Curt Weldon, Co-Founder of the Congressional Diabetes Caucus, to Champion Generex Initiatives in Asia and North America
6. Dendreon Announces Increased Capacity and Significant Reimbursement Decisions Supporting Broad Availability of PROVENGE
7. SCOLR Pharma, Inc. Announces Final Closing of Private Placement
8. Merrimack Announces Presentation of Preclinical Data at the 14th World Conference on Lung Cancer
9. Tengion Announces Leadership Transition
10. The Olive Branch Fund Announces Funding Award to Harvard Researcher
11. Verenium Announces Signing of Lease for New Office and Lab Space
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... September 19, 2014 Cereal grain ... industries will gather October 5–8, 2014, for the ... Island Convention Center in Providence, Rhode Island. The ... work of food scientists, chemists, microbiologists, nutritionists, and ... food production management. To date, 1,000 attendees have ...
(Date:9/19/2014)... ROCKLAND, Massachusetts , September 19, 2014 ... with the 53rd European Society for Paediatric Endocrinology (ESPE) ... advancement of science and medical research in the field ... of Merck KGaA, Darmstadt, Germany , ... Growth Innovation (GGI) for 2014. The awards were announced ...
(Date:9/18/2014)... September 18, 2014 Bipartisan passage this ... bill designed to stimulate development and commercialization of new ... praised by leaders of SPIE, the international society ... American Manufacturing and Innovation (RAMI) Act, now moves to ... have said they are optimistic that it will win ...
(Date:9/18/2014)... 2014 About POCT ... a clinical laboratory. It helps in making fast ... and medication. POCT is gaining popularity due to ... such as diabetes, heart disease, and obesity. It ... standardized to minimize errors during the diagnosis of ...
Breaking Biology Technology:Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 2EMD Serono Awards Grant for Growth Innovation (GGI) for the First Time 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3POCT Market in China 2014-2018 2
... LANSING, Mich., Sept. 22, 2011 Neogen Corporation (NASDAQ: ... test for aflatoxin, a toxin considered by many to be ... of mold growth in a wide range of commodities, including ... and animal health, more than 100 countries have established regulatory ...
... A team of researchers from Roche ( SIX: ... Research and Early Development and Roche NimbleGen, reported inGenome Research ... of the cynomolgus monkey ( Macaca fascicularis ) and developed ... use in preclinical drug safety research. The cynomolgus ...
... CRANBURY, N.J., Sept. 22, 2011 Palatin Technologies, Inc. ... developing bremelanotide for sexual dysfunction indications and PL-3994 for ... its fourth quarter and fiscal year ended June 30, ... Palatin initiated enrollment in its Phase 2B trial ...
Cached Biology Technology:Neogen Launches Fully Quantitative Lateral Flow Test for Aflatoxin 2Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment 2Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment 3Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 2Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 3Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 5
(Date:9/18/2014)... ability to acquire and creatively manipulate spoken language is ... the past 6 million years of human evolution to ... the best candidate gene we now have," says Wolfgang ... In his efforts to understand the molecular biological basis ... forward. The results of his latest study, undertaken in ...
(Date:9/18/2014)... turned its newborn screening program into a model other states ... the first-ever Newborn Screening Quality Award from the March of ... M.P.H., Arizona,s Department of Health Services director, with the award ... policy of full transparency for the length of time it ... lab for analysis, and set a target of having 95 ...
(Date:9/18/2014)... researchers from several disciplines will be celebrated tonight at ... roles in improving the health of premature infants and ... revolutions. The researchers, whose work was supported by the ... the former Atomic Energy Commission, will be honored at ... DC. A bipartisan group of Members of Congress will ...
Breaking Biology News(10 mins):Language evolution: Quicker on the uptake 2Language evolution: Quicker on the uptake 3March of Dimes honors Arizona with first-ever newborn screening award 2March of Dimes honors Arizona with first-ever newborn screening award 33rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2
... ancient microbes may not seem consequential, but such pioneering ... the state of modern human health. Cecil Lewis, assistant ... this research raise questions about the microbes living on ... Health initiative is looking at helpful bacteria found on ...
... A team of researchers at Princeton University and The ... gene that is fatefully switched on in 30 to ... disease, resisting traditional chemotherapies and eventually leading to death. ... in a small region of human chromosome 8 and ...
... 5, 2009Theodosius Dobzhansky, the late great geneticist and evolutionary ... except in the light of evolution." This year ... 1809) and the 150th anniversary of the publication of ... of evolution by means of natural selection in exquisite ...
Cached Biology News:Understanding extinct microbes may influence the state of modern human health 2Understanding extinct microbes may influence the state of modern human health 3Team finds breast cancer gene linked to disease spread 2Team finds breast cancer gene linked to disease spread 3Team finds breast cancer gene linked to disease spread 4Team finds breast cancer gene linked to disease spread 5GEN joins Charles Darwin 2009 celebration 2